Companies House does not verify the accuracy of the information filed(link opens a new window)
Advanced company searchLink opens in new window

EYEBIOTECH LIMITED

Company number 13503296

Follow this company File for this company

Persons with significant control: 1 active person with significant control / 0 active statements

Merck & Co., Inc. Active

Correspondence address
126 E. Lincoln Avenue, Rahway, New Jersey, United States, 07065-4646
Notified on
11 July 2024
Governing law
Legal form
Place registered
New York Stock Exchange
Registration number
7954610000
Incorporated in
New Jersey
Nature of control
Ownership of shares – 75% or more
Ownership of voting rights - 75% or more
Right to appoint or remove directors

Sv7 (Imf) Gp Llp On Behalf Of Sv7 Impact Medicine Fund Lp Ceased

Correspondence address
71 Kingsway, London, United Kingdom, WC2B 6ST
Notified on
3 February 2022
Ceased on
13 October 2023
Governing law
Legal form
Place registered
Companies House
Registration number
Oc425672
Incorporated in
England And Wales
Nature of control
Ownership of shares – More than 25% but not more than 50%
Ownership of voting rights - More than 25% but not more than 50%

Sv7 (Imf) Gp Llp On Behalf Of Sv7 Impact Medicine Fund Lp Ceased

Correspondence address
71 Kingsway, London, United Kingdom, WC2B 6ST
Notified on
9 July 2021
Ceased on
3 February 2022
Governing law
Legal form
Place registered
Companies House
Registration number
Oc425672
Incorporated in
England And Wales
Nature of control
Ownership of shares – 75% or more
Ownership of voting rights - 75% or more
Right to appoint or remove directors

Statement Withdrawn

The company knows or has reasonable cause to believe that there is no registrable person or registrable relevant legal entity in relation to the company
Notified on
21 March 2024
Withdrawn on
11 July 2024